Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-diabetic Adrenal Incidentaloma Patients

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Oct 23

PMID 24146977

Citations 7

Authors

Christian-Heinz Anderwald

Andrea Tura

Alois Gessl

Anton Luger

Giovanni Pacini

Michael Krebs

Affiliations

Soon will be listed here.

Abstract

Background: Insulin-resistance is commonly found in adrenal incidentaloma (AI) patients. However, little is known about beta-cell secretion in AI, because comparisons are difficult, since beta-cell-function varies with altered insulin-sensitivity.

Objectives: To retrospectively analyze beta-cell function in non-diabetic AI, compared to healthy controls (CON).

Methods: AI (n=217, 34%males, 57 ± 1 years, body-mass-index:27.7 ± 0.3 kg/m(2)) and CON [n = 25, 32%males, 56 ± 1 years, 26.7 ± 0.8 kg/m(2)] with comparable anthropometry (p ≥ 0.31) underwent oral-glucose-tolerance-tests (OGTTs) with glucose, insulin, and C-peptide measurements. 1mg-dexamethasone-suppression-tests were performed in AI. AI were divided according to post-dexamethasone-suppression-test cortisol-thresholds of 1.8 and 5 µg/dL into 3 subgroups: pDexa<1.8 µg/dL, pDexa1.8-5 µg/dL and pDexa>5 µg/dL. Using mathematical modeling, whole-body insulin-sensitivity [Clamp-like-Index (CLIX)], insulinogenic Index, Disposition Index, Adaptation Index, and hepatic insulin extraction were calculated.

Results: CLIX was lower in AI combined (4.9 ± 0.2 mg · kg(-1) · min(-1)), pDexa<1.8 µg/dL (4.9 ± 0.3) and pDexa1.8-5 µg/dL (4.7 ± 0.3, p<0.04 vs.CON:6.7 ± 0.4). Insulinogenic and Disposition Indexes were 35%-97% higher in AI and each subgroup (p<0.008 vs.CON), whereas C-peptide-derived Adaptation Index, compensating for insulin-resistance, was comparable between AI, subgroups, and CON. Mathematical estimation of insulin-derived (insulinogenic and Disposition) Indexes from associations to insulin-sensitivity in CON revealed that AI-subgroups had ~19%-32% higher insulin-secretion than expectable. These insulin-secretion-index differences negatively (r=-0.45, p<0.001) correlated with hepatic insulin extraction, which was 13-16% lower in AI and subgroups (p<0.003 vs.CON).

Conclusions: AI-patients show insulin-resistance, but adequately adapted insulin secretion with higher insulin concentrations during an OGTT, because of decreased hepatic insulin extraction; this finding affects all AI-patients, regardless of dexamethasone-suppression-test outcome.

Citing Articles

Cardiometabolic comorbidities and cardiovascular events in "non-functioning" adrenal incidentalomas: a systematic review and meta-analysis.

Favero V, Parazzoli C, Bernasconi D, Chiodini I J Endocrinol Invest. 2024; 47(12):2929-2942.

PMID: 39347906 PMC: 11549128. DOI: 10.1007/s40618-024-02440-0.

Glucose Alterations, Insulin Resistance, Arterial Hypertension, and Renin are Strictly Associated in Pediatric Obesity.

Antoniotti V, Amore M, Caputo M, Fania C, Mancioppi V, Casoli G J Endocr Soc. 2023; 7(8):bvad088.

PMID: 37424701 PMC: 10326241. DOI: 10.1210/jendso/bvad088.

Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR.

Wolf P, Dormoy A, Maione L, Salenave S, Young J, Kamenicky P Endocr Connect. 2022; 11(12).

PMID: 36269605 PMC: 9716376. DOI: 10.1530/EC-22-0296.

Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis.

Athanasouli F, Georgiopoulos G, Asonitis N, Petychaki F, Savelli A, Panou E Endocrine. 2021; 74(1):50-60.

PMID: 33963515 DOI: 10.1007/s12020-021-02741-x.

C-Peptide-based assessment of insulin secretion in the Zucker Fatty rat: a modelistic study.

Di Nardo F, Cogo C, Faelli E, Morettini M, Burattini L, Ruggeri P PLoS One. 2015; 10(5):e0125252.

PMID: 25938808 PMC: 4418729. DOI: 10.1371/journal.pone.0125252.

References

Isles C, Johnson J . Phaeochromocytoma and diabetes mellitus: further evidence that alpha 2 receptors inhibit insulin release in man. Clin Endocrinol (Oxf). 1983; 18(1):37-41. DOI: 10.1111/j.1365-2265.1983.tb03184.x. View

Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P . The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care. 2007; 30(9):2374-80. DOI: 10.2337/dc07-0422. View

Anderwald C, Tura A, Winhofer Y, Krebs M, Winzer C, Bischof M . Glucose absorption in gestational diabetes mellitus during an oral glucose tolerance test. Diabetes Care. 2011; 34(7):1475-80. PMC: 3120199. DOI: 10.2337/dc10-2266. View

Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof M . Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes. 2002; 51(10):3025-32. DOI: 10.2337/diabetes.51.10.3025. View

Muscogiuri G, Sorice G, Prioletta A, Mezza T, Cipolla C, Salomone E . The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?. Clin Endocrinol (Oxf). 2010; 74(3):300-5. DOI: 10.1111/j.1365-2265.2010.03928.x. View

Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein S . The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004; 25(2):309-40. DOI: 10.1210/er.2002-0031. View

Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Fazio S . Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab. 2002; 87(11):4872-8. DOI: 10.1210/jc.2001-011766. View

Anderwald C, Tura A, Grassi A, Krebs M, Szendroedi J, Roden M . Insulin infusion during normoglycemia modulates insulin secretion according to whole-body insulin sensitivity. Diabetes Care. 2011; 34(2):437-41. PMC: 3024363. DOI: 10.2337/dc10-1137. View

Anderwald C, Gastaldelli A, Tura A, Krebs M, Promintzer-Schifferl M, Kautzky-Willer A . Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab. 2010; 96(2):515-24. DOI: 10.1210/jc.2010-1398. View

10.

Bonadonna R, Stumvoll M, Fritsche A, Muggeo M, Haring H, Bonora E . Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes. 2003; 52(2):470-80. DOI: 10.2337/diabetes.52.2.470. View

11.

Stadler M, Pacini G, Petrie J, Luger A, Anderwald C . Beta cell (dys)function in non-diabetic offspring of diabetic patients. Diabetologia. 2009; 52(11):2435-2444. DOI: 10.1007/s00125-009-1520-7. View

12.

Fernandez-Real J, Engel W, Simo R, Salinas I, Webb S . Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma. Clin Endocrinol (Oxf). 1998; 49(1):53-61. DOI: 10.1046/j.1365-2265.1998.00437.x. View

13.

Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S . Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol. 2005; 153(6):837-44. DOI: 10.1530/eje.1.02045. View

14.

Tura A, Kautzky-Willer A, Pacini G . Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract. 2005; 72(3):298-301. DOI: 10.1016/j.diabres.2005.10.005. View

15.

Tura A, Ludvik B, Nolan J, Pacini G, Thomaseth K . Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001; 281(5):E966-74. DOI: 10.1152/ajpendo.2001.281.5.E966. View

16.

Beaudry J, Riddell M . Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development. Diabetes Metab Res Rev. 2012; 28(7):560-73. DOI: 10.1002/dmrr.2310. View

17.

Chiodini I, Morelli V, Salcuni A, Eller-Vainicher C, Torlontano M, Coletti F . Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab. 2010; 95(6):2736-45. DOI: 10.1210/jc.2009-2387. View

18.

Abdul-Ghani M, Jenkinson C, Richardson D, Tripathy D, DeFronzo R . Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006; 55(5):1430-5. DOI: 10.2337/db05-1200. View

19.

Elbein S, Wegner K, Kahn S . Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds. Diabetes Care. 2000; 23(2):221-7. DOI: 10.2337/diacare.23.2.221. View

20.

Nieman L, Biller B, Findling J, Newell-Price J, Savage M, Stewart P . The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008; 93(5):1526-40. PMC: 2386281. DOI: 10.1210/jc.2008-0125. View